Better Therapeutics, Inc. - Common Stock (NQ:BTTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	0.0360 (500)
Ask (Size)	0.0370 (3)
Prev. Close	0.0446
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	31,731,352
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 15, 2024

Via Benzinga

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 15, 2024

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Via Benzinga

Performance

More News

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 15, 2024

Via Benzinga

Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales ↗

March 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 15, 2024

Via Benzinga

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

March 15, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 15, 2024

Via InvestorPlace

Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views ↗

March 14, 2024

Via Benzinga

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 14, 2024

Via Benzinga

Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings ↗

March 14, 2024

Via Benzinga

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

March 14, 2024

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

March 05, 2024

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 04, 2024

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease

February 26, 2024

Via News Direct

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

February 20, 2024

From Better Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 12, 2024

Via Benzinga

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

February 06, 2024

From Better Therapeutics Inc.

Via Business Wire

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

January 17, 2024

From Better Therapeutics Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 11, 2024

Via Benzinga

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

January 04, 2024

From Better Therapeutics

Via Business Wire

Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket ↗

January 02, 2024

Via Benzinga

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

January 02, 2024

From Better Therapeutics, Inc.

Via Business Wire

Frequently Asked Questions

Is Better Therapeutics, Inc. - Common Stock publicly traded?

Yes, Better Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Better Therapeutics, Inc. - Common Stock trade on?

Better Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Better Therapeutics, Inc. - Common Stock?

The ticker symbol for Better Therapeutics, Inc. - Common Stock is BTTX on the Nasdaq Stock Market